A Safe and Effective Solution for More Women
Unlike older endometrial ablation methods that have strict patient exclusions, Minitouch is designed to treat a broader range of women, including those who are traditionally considered high-risk or ineligible for other procedures.
With its gentle, low-temperature energy delivery and no need for general anesthesia, Minitouch offers consistent, excellent outcomes for a diverse patient population.
Same Excellent Outcomes Regardless of Covariates
Clinical studies show that Minitouch delivers equally successful outcomes across a variety of patient backgrounds, including:
94% of patients experienced a significant reduction in bleeding, and 95% reported a reduction in period pain—with no difference in success rates based on patient history or uterine variations.
A Solution for Patients Contraindicated for General Anesthesia or IV Sedation
Many women cannot or prefer not to undergo general anesthesia or IV sedation, making them ineligible for traditional ablation methods. Minitouch eliminates this barrier by providing:
01
A completely in-office procedure
no hospital stay required
02
A gentle experience without IV sedation
reducing risks for high-risk patients
03
A safer alternative for women with anesthesia
sensitivities or medical contraindications
This means more women can access a long-term solution for heavy periods, without the risks associated with surgery or aggressive ablation techniques.
Minitouch provides a safe, effective treatment option
for more women, including those who cannot tolerate anesthesia or other invasive procedures.